Skip to Content

93 64 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint 93 64 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 64

Rabeprazole sodium delayed-release 20 mg 93 64
Rabeprazole sodium delayed-release 20 mg 93 64
Rabeprazole sodium delayed-release 20 mg 93 64
Rabeprazole sodium delayed-release 20 mg 93 64

Rabeprazole Sodium Delayed-Release

Imprint
93 64
Strength
20 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-0064 Teva Pharmaceuticals USA, Inc.
42291-0721 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "93 64"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.